S-substituted quinazolines and their therapeutic applications for the treatment of diseases mediated by PDE7

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9796687
SERIAL NO

15157060

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a family of S-substituted quinazoline derivatives that inhibitors of the enzyme phosphodiesterase 7 (PDE7), useful for the treatment or prevention of diseases mediated by said enzyme, especially inflammatory, neurodegenerative, neurological, psychiatric and/or autoimmune diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Garcia, Fernandez Ana Maria Membrilla, ES 1 0
Gil, Ayuso-Gontan Carmen Belen Talavera de la Reina, ES 1 0
Martinez, Gil Ana Madrid, ES 18 10
Perez, Fernandez Daniel Ignacio Madrid, ES 4 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 24, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 24, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00